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Background: Abdominal obesity is a more important risk factor than overall obesity in predicting the development
of type 2 diabetes and cardiovascular disease. From a preventive and public health point of view it is crucial that
risk factors are identified at an early stage, in order to change and modify behaviour and lifestyle in high risk
individuals.
Methods: Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular
disease and prevalence of metabolic syndrome in middle-aged men. In order to identify those with increased risk
for type 2 diabetes and/or cardiovascular disease sensitivity and specificity analysis were performed, including
calculation of positive and negative predictive values, and corresponding 95% CI for eleven different cut-off points,
with 1 cm intervals (92 to 102 cm), for waist circumference.
Results: A waist circumference ≥94 cm in middle-aged men, identified those with increased risk for type 2
diabetes and/or for cardiovascular disease with a sensitivity of 84.4% (95% CI 76.4% to 90.0%), and a specificity of
78.2% (95% CI 68.4% to 85.5%). The positive predictive value was 82.9% (95% CI 74.8% to 88.8%), and negative
predictive value 80.0%, respectively (95% CI 70.3% to 87.1%).
Conclusions: Measurement of waist circumference in middle-aged men is a reliable test to identify individuals at
increased risk for type 2 diabetes and cardiovascular disease. This measurement should be used more frequently in
daily practice in primary care in order to identify individuals at risk and when planning health counselling and
interventions.
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It is well known that an unhealthy and sedentary lifestyle
is associated with an increased risk for obesity. Besides
the well recognized cardiovascular disease (CVD) co-
morbidities and risk factors including type 2 diabetes
(T2D), hypertension, and dyslipidemia, obesity is also by
itself one major CVD risk factor [1]. Abdominal obesity is
a stronger risk factor than overall obesity – often
expressed as body mass index (BMI) – for the future de-
velopment of T2D and CVD [2-4]. From a preventive and* Correspondence: johan.eriksson@helsinki.fi
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reproduction in any medium, provided the orpublic health point of view it is crucial that risk factors
are identified at an early stage, in order to change and
modify behaviour and lifestyle in high risk individuals.
Several screening procedures, tests and questionnaires
are available to assess future risk for type 2 diabetes and
cardiovascular disease [5,6]. In an often hectic primary
care setting, however, the use of questionnaires is often
too time consuming. One single measurement of ab-
dominal obesity – i.e., waist circumference − is easy to
perform and it is known to associate closely with type 2
diabetes and cardiovascular disease [7]. However, cut-off
values for abdominal obesity predicting future type 2
diabetes and cardiovascular disease are known to be
population specific [8,9]. The aim of the present study
was to assess the predictive value of one singled. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Flow chart and baseline characteristics of the study.
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Helsinki Health Centre and Helsinki Heart District car-
ried out a study to assess the prevalence of the metabolic
syndrome (MetS) among middle-aged men in the city of
Helsinki, between the years 2001 and 2003. The aim of
that study, the MBO-project, was to create a screening
system to make middle-aged men aware of their poten-
tial risk for type 2 diabetes and cardiovascular disease
[10]. In year 2001 all men aged 40, 45, 50, and 55 years
living in the north-east district of Helsinki were invited
to participate in a type 2 diabetes and cardiovascular dis-
ease risk assessment visit at their local Health Center.
Approval of the study protocol was obtained from the
Epidemiological Ethics Committee of Helsinki and Uusi-
maa Hospital District. Each participant gave his written
informed consent. During the appointment with the
trained nurses the participants completed one type 2
diabetes (FINDRISC) and one cardiovascular disease
(The Modified North Karelia project risk index) [5,6]
questionnaire and they were interviewed about their
lifestyle.
Blood pressure was measured in the sitting position,
the mean of two measurements was used. Height was
measured without shoes on to the nearest 0,1 cm, and
weight was measured in light indoor clothing to the
nearest 0.1 kg. BMI was calculated. Waist circumference
was measured in the standing position, midway between
the lowest rib and iliac crest, directly on the skin. All
measurements were made by trained nurses according
to standard techniques. Blood samples were drawn by a
trained technician and analysed in a certified central la-
boratory for fasting lipids and glucose. Those with a
CVD Risk Score of ≥ 4.5 received individualized lifestyle
counselling based on their own risk profile. Those men
at high risk had a follow-up visit 6 months later to
evaluate the impact of the health counselling. Briefly, the
observed reduction in CVD Risk Score was significant
[10]. Based on the encouraging results of the original
MBO project, Helsinki Health Centre is yearly inviting
all men aged 40 years for risk evaluation and health-
counselling visits. In the present study we focus upon
men aged 40 years because they present the age group
with the lowest morbidity and are potentially most suit-
able for preventive measures. Figure 1 shows the flow
chart of the study and the number of men included.
Questionnaires
The Diabetes Risk Score (FINnish Diabetes Risk Score –
FINDRISC) has been developed at the National PublicHealth Institute of Finland and the validity of the test
has been assessed by the same institute in an independ-
ent population survey [5]. The Diabetes Risk Score takes
into account: age, BMI, waist circumference, exercise
habits, dietary habits (intake of vegetables and berries),
medication for elevated blood pressure, history of hyper-
glycemia, and family history of diabetes. A person with a
risk score of 7 has at least 4 times higher risk to develop
type 2 diabetes within 10 years than those whose risk
score is below 7. The FINDRISC questionnaire can be
accessed at www.diabetes.fi/english.
Table 1 General characteristics of the study sample
n Mean SD Minimum Maximum
Systolic BP mmHg
All 196 130.2 15.1 96 186
FINDRIC ≥ 7 82 133.6 14.8 110 186
CVD Risk Score ≥ 4.5 114 137.5 15.2 100 186
Diastolic BP mmHg
All 196 86.2 9.6 65 120
FINDRISC ≥ 7 82 89.3 9.2 72 120
CVD Risk Score ≥ 4.5 114 92.5 10.1 66 120
Total cholesterol mmol/l
All 196 5.06 1.08 2.8 8.2
FINDRISC ≥ 7 82 5.28 1.07 3.3 8.0
CVD Risk Score ≥ 4.5 114 5.88 1.02 3.5 8.3
LDL cholesterol mmol/l
All 150 3.13 1.15 0.52 6.62
FINDRISC ≥ 7 71 3.24 1.06 0.52 6.38
CVD Risk Score ≥ 4.5 109 3.84 0.93 1.71 6.62
HDL cholesterol mmo/l
All 150 1.44 0.45 0.78 2.59
FINDRISC ≥ 7 72 1.32 0.40 0.78 2.59
CVD Risk Score ≥ 4.5 110 1.33 0.35 0.76 2.67
Triglycerides mmol/l
All 150 1.69 0.73 0.53 4.46
FINDRISC ≥ 7 72 1.84 0.88 0.54 4.46
CVD Risk Score ≥ 4.5 110 1.67 0.78 0.53 4.36
Glucose mmol/l
All 150 5.37 0.59 4.2 8.2
FINDRISC ≥ 7 70 5.38 0.53 4.5 7.0
CVD Risk Score ≥ 4.5 111 5.45 0.48 4.3 7.0
BMI kg/m2
All 196 26.2 3.8 18 44
FINDRIC ≥ 7 82 28.9 3.7 22 44
CVD Risk Score ≥ 4.5 114 28.1 4.0 18 44
WC cm
All 196 96.6 10.4 76 142
FINDRISC ≥ 7 82 104.1 10.0 81 142
CVD Risk Score ≥ 4.5 114 101.5 10.4 82 142
FINDRISC
All 196 5.8 3.6 0 18
FINDRISC ≥ 7 82 9.2 2.4 7 18
CVD RISK Score ≥ 4.5 82 4.8 2.7 0.5 11.5
CVD Risk Score
All 196 3.8 2.6 0 18
FINDRISC ≥ 7 67 7.5 3.6 0 18
CVD Risk Score ≥ 4.5 105 6.7 1.8 4.5 12
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North Karelia project risk index is based on BMI, history
of smoking, exercise habits, systolic and diastolic blood
pressure, and total cholesterol concentration [6].
Depending on the risk factor status a person can have
risk points from zero to sixteen. A person with at least
4.5 points is at high risk for cardiovascular diseases. The
validity of the CVD Risk Score has recently been
assessed [11].
Analysis
We identified subjects with a risk score for type 2 dia-
betes ≥7 and subjects with a risk score for cardiovascular
disease ≥4.5 from the study sample. Combining these
two risk scores we identified subjects who had at least
one of these risk scores elevated. The cut-off point for
waist circumference was defined as the “positive test
quantity”. Waist circumference was entered in the risk
equation as a continuous variable. By cross tabulating
frequencies of different categories we performed sensi-
tivity and specificity analysis including positive and
negative predictive values, and corresponding 95% CI for
eleven different cut-off points (92 to 102 cm) of waist
circumference. A ROC curve was plotted; sensitivity on
the vertical axis and 1− specificity on the horizontal axis.
When identifying frequencies and constructing the ROC
curve we used the statistical program SPSS 16.0 for
Windows (SPSS Inc., Chicago IL, USA). The sensitivity
and specificity of the test with the positive, and the
negative predictive values as well as the corresponding
confidence intervals were calculated with the Confidence
Interval Analysis (CIA) program for Windows according
to Wilson’s method.
Results
Of the invited persons, 234 (32.7%) men participated,
and provided baseline data. Waist circumference meas-
urement of two men was missing. In the study sample
median waist circumference was 95 cm and the range
was 72 to 142 cm. Baseline characteristics of the study
participants are shown in Table 1. The FINDRISC ques-
tionnaire was incomplete for 36 participants because the
questionnaire was not yet available at the beginning of
the MBO project. Both risk assessment tests were avail-
able for 196 men. Among these, 82 had a risk score for
T2DM ≥7, and 67 had a risk score for CVD ≥4.5. At
least one of the risk scores was elevated in 109 men,
whereas both risk scores were elevated in 40. The per-
centiles, sensitivity, specificity, positive and negative pre-
dictive values of different cut-off points for waist
circumferences are shown in Table 2. In this study popu-
lation a cut-off point for waist circumference ≥94 cm
identified subjects with increased risk for type 2 diabetes
or for cardiovascular disease more precisely than anyBMI, body mass index; WC, waist circumference.
Table 2 Sensitivity, specificity, PPV and NPV
corresponding to different waist circumference cut-offs
Cut-off Percentile Sensitivity Specificity PPV NPV
cm % % % %
92 38.8 88.1 62.1 74.4 80.6
93 43.4 85.3 69.0 77.5 78.9
94 47.4 84.4 78.2 82.9 80.0
95 51.0 79.8 81.6 84.5 76.3
96 57.1 74.3 82.8 84.4 72.0
97 59.2 65.1 85.1 84.5 66.1
98 63.8 64.2 88.5 87.5 66.4
99 66.3 57.8 90.8 88.7 63.2
100 71.9 53.2 90.8 87.9 60.8
101 75.5 46.8 95.4 92.7 58.9
102 77.6 41.3 96.6 93.8 56.8
PPV, positive predictive value; NPV, negative predictive value.
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84.4% (95% CI 76.6% to 90.0%), specificity 78.2% (95%
CI 68.4% to 85.5%), positive predictive value 82.9% (95%
CI 74.8% to 88.8%), and negative predictive value 80.0%
(95% CI 70.3% to 87.1%), respectively. The sum of false
positives (19/111) and false negatives (17/85) was smal-
lest at the same cut-off point (≥94 cm). The area under
the ROC curve was 0.857 (95% CI 0.805 to 0.909). The
ROC curve is shown in Figure 2.Figure 2 ROC curve.Discussion
Abdominal obesity, often expressed as an increased
waist circumference, is becoming a widely accepted an-
thropometric measurement when assessing overall cardi-
ometabolic risk. Several studies have shown that
abdominal obesity correlates well with obesity related
CVD risk factors including elevated blood pressure, dys-
lipidemia, and hyperglycemia [12,13]. Associations be-
tween waist circumference and type 2 diabetes and
CVD-associated morbidity have also been demonstrated
[14,15]. To our knowledge there is only one previous
study focusing upon the association between waist cir-
cumference and future risk for type 2 diabetes/CVD
assessing risk by applying a risk score equation [16].
From a public health point of view this is an important
issue especially within primary care when aiming at early
identification of high risk individuals. When estimating
risk for CVD the CVD Risk Score compares well with
SCORE relative risk chart [17]. The latter identified
87.6% of those with a CVD Risk Score ≥ 4.5 in our study,
into the elevated risk category. Extrapolating those with
CVD Risk Score ≥ 4.5 to 60 years of age in the SCORE
risk chart, 88.6% had an absolute risk of ≥5%. These
findings support the use of the CVD Risk Score as a
screening tool in middle-aged men.
Waist circumference ≥ 94 cm is a compulsatory criter-
ion for the metabolic syndrome (MetS) according to the
criterion put forward by International Diabetes Feder-
ation (IDF). We applied IDF´s criteria to our study
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MetS and hence an increased risk of developing type 2
diabetes and/or CVD, whereas our method identifies
46% of the men from the same population with
increased risk of developing type 2 diabetes and/or
CVD. In the present study we demonstrated that among
middle-aged men a cut-off point for waist circumference
≥94 cm detected with excellent precision those at
increased risk of developing type 2 diabetes and/or
CVD. The outcome variable; merged diabetes risk score
and CVD Risk Score consist of a large number of cardio
metabolic risk factors. By applying thresholds for dia-
betes risk score ≥7 and for CVD Risk Score ≥4.5, we
avoided the possibility that only one single risk factor
could lead to a positive outcome level. The highest
single diabetes risk score (5 points) is obtained by an in-
dividual who at least occasionally have an elevated glu-
cose level or who has a first-degree relative with
diabetes. The highest single CVD Risk Score (4 points)
is obtained by heavy smoking (at least 30 cigarettes per
day) or by having a total cholesterol ≥ 8.5 mmol/l. Be-
ginning in adolescent the risk characteristics accumu-
lates little by little depending on the lifestyle. Already at
the age of 15 years; boys have a significantly higher risk
for CVD with WC ≥75th percentiles compared those
with WC ≤25th percentiles [18]. Restoring to the former
condition is more and more difficult in societies of
today. In a 5 years follow-up study only overweight
younger middle-aged men benefit from weight reduction
regarding major CVD events whereas weight loss was
associated with significant risk reduction in all age-
groups regarding type 2 diabetes [19]. As the outcome
variable is set to relative low level the test can identify
subjects in the phase where the modification of lifestyle
still has an impact on major risk factors. The measure-
ment of waist circumference is an easy way to get reli-
able information of the risk for type 2 diabetes and CVD
in the often hectic primary care settings. When the waist
circumference measurement gives an alarm the practi-
tioner has a method for the risk assessment for type 2
diabetes and for CVD to determine whether the alarm
calls for lifestyle intervention. The main weakness of this
study was the relatively small study sample. As we stud-
ied only Finnish men aged 40 years it is not possible to
generalise the results into other age-groups. Further
studies are also needed to determine cut-offs for women
and for men other than Caucasian [20]. We demon-
strated the capability of the “two phase screening
method” to identify people at an increased risk for type
2 diabetes and for cardiovascular disease. This method is
easy to apply in general practice. Implementation of the
method is potentially challenging in the primary health
care setting due to the rapid grow in prevalence of obes-
ity. Therefore, it is important to incorporate the wholeteam and involve public health nurses to participate in
identification and prevention of type 2 diabetes and car-
diovascular disease.
Conclusions
We conclude that a waist circumference above 94 cm
was found to be most predictive in identifying middle-
aged men having a high risk to develop type 2 diabetes
or cardiovascular disease. It should therefore be used
more in every day practice to identify individuals at risk.
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